FACILITATED ISOLATION, PURIFICATION, AND ANALYSIS OF GLUCURONOXYLOMANNAN OF CRYPTOCOCCUS-NEOFORMANS

被引:118
作者
CHERNIAK, R
MORRIS, LC
ANDERSON, BC
MEYER, SA
机构
关键词
D O I
10.1128/IAI.59.1.59-64.1991
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cryptococcus neoformans was cultured in a chemically defined medium. The culture was adjusted to 0.25% formaldehyde or autoclaved after 5 days of growth at 35-degrees-C, and a cell-free supernatant was obtained by centrifugation. Solid calcium acetate was added to the supernatant to give a 5% solution, and the pH was adjusted to approximately 5 with glacial acetic acid. The polysaccharide (PS) was precipitated by the addition of 3 volumes of 95% ethanol. The PS was dissolved in 0.2 M NaCl, and insoluble calcium salts were solubilized by the addition of several drops of glacial acetic acid. The PS solution was treated by ultrasonic irradiation for 15 min. This concurrently decreased the molecular weight of the PS and reduced the viscosity of the solution. The ultrasonically irradiated PS was precipitated by differential complexation with hexadecyltrimethylammonium bromide at 23-degrees-C, the complex was dissolved in 1 M NaCl, and the glucuronoxylomannan was precipitated by adding 3 volumes of ethanol. The glucuronoxylomannan was dissolved in 1 M NaCl and then ultrasonically irradiated for 2 h to reduce the molecular mass to a limiting value of approximately 100 kDa (GXMS). The purified GXMS was centrifuged, dialyzed, and finally recovered by lyophilization. GXMS was chromatographed on DEAE-cellulose at reasonable concentrations without the complication of high solution viscosity. The sugar composition and structure of GXMS were determined by gas-liquid chromatography, permethylation gas-liquid chromatography-mass spectrometry, and C-13 nuclear magnetic resonance spectroscopy. The improved solution characteristics of GXMS were ideal for the determination of its chemical and serological properties.
引用
收藏
页码:59 / 64
页数:6
相关论文
共 31 条
[1]  
BENNETT JE, 1965, J IMMUNOL, V94, P916
[2]  
BHATTACHARJEE AK, 1984, REV INFECT DIS, V6, P619
[3]   INVESTIGATIONS ON STRUCTURE OF CAPSULAR POLYSACCHARIDE FROM CRYPTOCOCCUS NEOFORMANS TYPE B [J].
BLANDAMER, A ;
DANISHEFSKY, I .
BIOCHIMICA ET BIOPHYSICA ACTA, 1966, 117 (02) :305-+
[4]   NEW METHOD FOR QUANTITATIVE-DETERMINATION OF URONIC ACIDS [J].
BLUMENKR.N ;
ASBOEHAN.G .
ANALYTICAL BIOCHEMISTRY, 1973, 54 (02) :484-489
[5]   CRYPTOCOCCAL CAPSULAR POLYSACCHARIDE-INDUCED MODULATION OF MURINE IMMUNE-RESPONSES [J].
BREEN, JF ;
LEE, IC ;
VOGEL, FR ;
FRIEDMAN, H .
INFECTION AND IMMUNITY, 1982, 36 (01) :47-51
[6]   CRYPTOCOCCUS NEOFORMANS .3. INHIBITION OF PHAGOCYTOSIS [J].
BULMER, GS ;
SANS, MD .
JOURNAL OF BACTERIOLOGY, 1968, 95 (01) :5-&
[7]  
Cherniak R, 1988, Curr Top Med Mycol, V2, P40
[8]  
CHERNIAK R, 1988, DIAGN CLIN IMMUNOL, V5, P344
[9]   A GALACTOXYLOMANNAN ANTIGEN OF CRYPTOCOCCUS-NEOFORMANS SEROTYPE-A [J].
CHERNIAK, R ;
REISS, E ;
TURNER, SH .
CARBOHYDRATE RESEARCH, 1982, 103 (02) :239-250
[10]  
CHERNIAK R, 1988, CARBOHYD RES, V181, P1